Hosted by the School of Cellular and Molecular Medicine

Dr. Cagan received his Ph.D. from Princeton University. After a postdoctoral fellowship at UCLA, he achieved the rank of Professor at Washington University School of Medicine (1993-2007), then at Icahn School of Medicine at Mount Sinai (2007-2020).

He is currently Regius Professor of Precision Medicine and Royal Society Wohl Fellow at University of Glasgow, and Senior Editor of the journal Disease Models and Mechanisms.

He was co-Founder and board member of the biotechnology company Medros Inc. and is co-Founder of the emerging company Flight Path.

Taking advantage of a century of powerful genetic tools, his laboratory has developed highly complex, whole animal models for cancer and inherited genetic diseases. Their work helped promote the first FDA-approved chemotherapeutic for Medullary Thyroid Carcinoma.

Working with the chemist Arvin Dar and computational chemist Avner Schlessinger, his laboratory has developed a novel platform that combines genetics with medicinal and computational chemistry to build novel lead compounds that emphasize rational polypharmacology.

Leveraging these new technologies, Dr. Cagan leads the Center for Personalized Cancer Therapeutics team that develops and treats thyroid and colorectal cancer patients through a personalized fly-to-bedside, open label clinical trial.

For further information and to view recent publications, please visit Professor Cagan's institutional profile page.

Zoom Joining Link: https://bristol-ac-uk.zoom.us/j/95732971461